carisoprodol
Generic: carisoprodol
Labeler: ingenus pharmaceuticals, llcDrug Facts
Product Profile
Brand Name
carisoprodol
Generic Name
carisoprodol
Labeler
ingenus pharmaceuticals, llc
Dosage Form
TABLET
Routes
Active Ingredients
carisoprodol 350 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50742-656
Product ID
50742-656_372a2c87-8153-403b-8f40-851e1dddd809
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040823
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2019-05-21
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50742656
Hyphenated Format
50742-656
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carisoprodol (source: ndc)
Generic Name
carisoprodol (source: ndc)
Application Number
ANDA040823 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 350 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (50742-656-01)
- 500 TABLET in 1 BOTTLE (50742-656-05)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "372a2c87-8153-403b-8f40-851e1dddd809", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0350742656011", "0350742656059"], "unii": ["21925K482H"], "rxcui": ["197446"], "spl_set_id": ["5eff5b4c-c363-45b5-9eef-b724233a51e2"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50742-656-01)", "package_ndc": "50742-656-01", "marketing_start_date": "20190521"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (50742-656-05)", "package_ndc": "50742-656-05", "marketing_start_date": "20190521"}], "brand_name": "CARISOPRODOL", "product_id": "50742-656_372a2c87-8153-403b-8f40-851e1dddd809", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "50742-656", "dea_schedule": "CIV", "generic_name": "CARISOPRODOL", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARISOPRODOL", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "350 mg/1"}], "application_number": "ANDA040823", "marketing_category": "ANDA", "marketing_start_date": "20190521", "listing_expiration_date": "20261231"}